Liposomal MTP-PE.

Subjects

Subjects :

Acetylmuramyl-Alanyl-Isoglutamine administration & dosage
Acetylmuramyl-Alanyl-Isoglutamine adverse effects
Acetylmuramyl-Alanyl-Isoglutamine pharmacokinetics
Acetylmuramyl-Alanyl-Isoglutamine pharmacology
Antineoplastic Agents adverse effects
Antineoplastic Agents pharmacokinetics
Antineoplastic Agents pharmacology
Clinical Trials as Topic
Drug Carriers
Humans
Immunologic Factors adverse effects
Immunologic Factors pharmacokinetics
Immunologic Factors pharmacology
Liposomes
Melanoma drug therapy
Osteosarcoma drug therapy
Phosphatidylethanolamines adverse effects
Phosphatidylethanolamines pharmacokinetics
Phosphatidylethanolamines pharmacology
Acetylmuramyl-Alanyl-Isoglutamine analogs & derivatives
Antineoplastic Agents administration & dosage
Immunologic Factors administration & dosage
Phosphatidylethanolamines administration & dosage

Details

Language :

English

ISSN :

1043-4542

Volume :

11

Issue :

4

Database :

MEDLINE

Journal :

Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses

Publication Type :

Academic Journal

Accession number :

7946146

Full Text :

https://doi.org/10.1177/104345429401100407